<
Bioterrorism and Vaccine Update

Bioterrorism: A New Challenge for the Allergist
Daniel Rotrosen, MD, Director, Div. of All/Imm and Transplantation, NIAID

Update on Vaccines for the Allergist: The Good
Joseph A. Bellanti, MD

Update on Vaccines for the Allergist: The Bad
Renata J.M. Engler, MD

Update on Vaccines for the Allergist: The Ugly
Theodore M. Freeman, MD


Emerging Therapies

Overview of Immunomodulatory Strategies
Thomas B. Casale, MD
Alpha and Omega of Therapeutic Approaches: Oral Immunotherapy and PDE4 Antagonists
John J. Condemi, MD


Ethical Issues in Clinical Research
Why Do A Placebo-Controlled Trial
Mark S. Dykewicz, MD
Ethics of Placebo-Controlled Studies
Jonathan Moreno, PhD


Environmental Molds

Biology of Molds
Elliott Horner, PhD
Home Assessments: How They Are Done
Joseph Fedoruk
Jean A. Chapman Lecture
Health Effects of Mold Exposure and How to Evaluate Patients Who Think They Have It

Emil J. Bardana, Jr., MD

Mold in Schools
John Santilli, MD
Legal Aspects of Mold
Court Purdy, JD

Controversies in Sinusitis

John McGovern Lecture
Hyperplastic Sinusitis: Atopic Inflammation and Its Appropriate Management

Supported by an educational grant from the John P. McGovern Foundation

Larry Borish, MD
Bernard Berman Memorial Lecture
Allergic Fungal Sinusitis


Richard D. deShazo, MD
Management of Sinus Headache: Is it a Migraine Variant?
Stewart Tepper, MD

Question and Answer Session
Panel


Evaluation and Management of Acute Severe Asthma

Assessment of Severity of Acute Asthma
Bradley E, Chipps, MD
Bronchodilatory Therapy: Delivery Systems and Dosing Strategies
John J. Oppenheimer, MD
Corticosteroid: Oral, Parenteral, Inhaled
Christopher G. Fanta, MD

Alternative Treatment Strategies: LTRA, MGS04, He/O2, non-invasive vent
Thomas Corbridge, MD


Urticaria: Its Pathophysiology and Management

Daniel Goodman Lecture
Autoimmune Issues in Urticaria
Allen P. Kaplan, MD
Urticarial Vasculitic Syndromes
Albert F. Finn, Jr., MD
Difficult to Manage Urticaria Patient
Roger W. Fox, MD
Question and Answer Session
Panel


Rheumatology for the Allergist

Rheumatologic Disorders Masquerading as Allergic Diseases
Marianne Frieri, MD, PhD
Diagnostic Utility of Antinuclear and Anticytoplasmic Antibodies for the Non Rheumatologist
John J. Condemi, MD
Are Silicone Breast Implants Associated with Autoimmunity?
Henry N. Claman, MD
Question and Answer Session
Panel


JCAAI Session

Remodeling Our National System for Protection of Human Subjects in Research
Debra R. Lappin, JD
Question and Answer Session
Panel


Stanislaus Jaros Lecture

Atopic Dermatitis - Is It Skin Allergy?
Donald Y.M. Leung, MD

Annual Business Meeting

Annual Business Meeting
Bobby Q. Lanier, MD, Presiding

The Road to Improvement: Oral Immunotherapy – An Alternative to Conventional Immunotherapy

Bela Schick Lecture
Allergy Training Programs – Are the Golden Days Over?


Richard W. Weber, MD
Oral and Sublingual Immunotherapy – Italian Experience
Giorgio W. Canonica, MD


Oral Immunotherapy – American Experience
Dale T. Umetsu, MD

The Case for Sublingual Immunotherapy – European and Swiss Experience
Martin K. Kägi, MD

The Case Against Oral Immunotherapy
Jay M. Portnoy, MD

Legal and Ethical Implications of Using Methods of Immunotherapy Not FDA Approved
Richard Verville, JD

Question and Answer Session
Panel


Anaphylaxis

Mechanisms of Anaphylaxis
Richard W. Weber, MD
Anaphylaxis in the Office – Allergists Be Prepared
Dana V. Wallace, MD

Are We Prepared? Where Do We Stand?


Immunologic Skin Disease

Autoimmune Blistering Skin Diseases
Grant J. Anhalt, MD
Contact Dermatitis: the Eyelids as a Paradigm
Jere Guin, MD

Pathophysiology of Atopic Dermatitis
Ernest N. Charlesworth, MD

Questions and Answer Session
Panel